<--- Back to Details
First PageDocument Content
Fertility / In vitro fertilisation / Preimplantation genetic diagnosis / Ovarian hyperstimulation / Transvaginal oocyte retrieval / Human chorionic gonadotropin / Assisted reproductive technology / Gonadotropin-releasing hormone antagonist / Gonadotropin-releasing hormone agonist / Fertility medicine / Human reproduction / Medicine
Fertility
In vitro fertilisation
Preimplantation genetic diagnosis
Ovarian hyperstimulation
Transvaginal oocyte retrieval
Human chorionic gonadotropin
Assisted reproductive technology
Gonadotropin-releasing hormone antagonist
Gonadotropin-releasing hormone agonist
Fertility medicine
Human reproduction
Medicine

Experimental research Comparisons of the effects of long-acting and

Add to Reading List

Source URL: www.ncbi.nlm.nih.gov

Download Document from Source Website

File Size: 456,56 KB

Share Document on Facebook

Similar Documents

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1  1.

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1.

DocID: 16voX - View Document

IVF/GIFT Elonva® applications  Purpose of this form Filling in this form

IVF/GIFT Elonva® applications Purpose of this form Filling in this form

DocID: UsX0 - View Document

SOGC CLINICAL PRACTICE GUIDELINE No. 315, November 2014 The Prevention of Ovarian Hyperstimulation Syndrome This clinical practice guideline has been prepared by the

SOGC CLINICAL PRACTICE GUIDELINE No. 315, November 2014 The Prevention of Ovarian Hyperstimulation Syndrome This clinical practice guideline has been prepared by the

DocID: JtWT - View Document

SOGC CLINICAL PRACTICE GUIDELINE No. 315, November 2014 The Prevention of Ovarian Hyperstimulation Syndrome This clinical practice guideline has been prepared by the

SOGC CLINICAL PRACTICE GUIDELINE No. 315, November 2014 The Prevention of Ovarian Hyperstimulation Syndrome This clinical practice guideline has been prepared by the

DocID: ISkM - View Document

SOGC CLINICAL PRACTICE GUIDELINE No. 315, November 2014 The Prevention of Ovarian Hyperstimulation Syndrome This clinical practice guideline has been prepared by the

SOGC CLINICAL PRACTICE GUIDELINE No. 315, November 2014 The Prevention of Ovarian Hyperstimulation Syndrome This clinical practice guideline has been prepared by the

DocID: IJbr - View Document